KOL Luncheon: Novel Treatments for Alström Syndrome, hosted by Prometic Life Sciences Inc.

The meeting will feature presentations by KOLs Manal F. Abdelmalek, MD, MPH (Duke University School of Medicine), and Patrick Colin, BPharm, PhD (PCC Inc.), who will discuss the current treatment landscape, clinical development pipeline, the unmet medical need for treating patients with insulin resistance syndrome or Alström Syndrome (AS).